Table 4.
Adverse events of the patient subgroup
| Control group | Experimental group | ||||||
|---|---|---|---|---|---|---|---|
| Grade 2 | Grade 3 | Grade 4 | Grade 5 | Grade 2 | Grade 3 | ||
| Laboratory abnormalities | |||||||
| Anemia | 1 | 1 | None | none | None | None | |
| Increased ALT/AST | 2 | None | None | none | None | None | |
| Clinical adverse events | |||||||
| Abdominal pain | 1 | None | None | None | None | None | |
| Cardiac arrest | None | None | None | 1 | None | None | |
| Cerebral infarction | None | None | 1 | None | None | None | |
| Constipation | 2 | None | None | None | None | None | |
| Diarrhea | 1 | None | None | None | 3 | None | |
| Dyspepsia | 1 | None | None | None | None | None | |
| Fatigue | 5 | None | None | None | None | None | |
| Headache | None | None | None | None | 1 | None | |
| Hypertension | 1 | 1 | None | None | 2 | None | |
| Lethargy | 1 | None | None | None | None | None | |
ALT Alanine aminotransferase; AST Aspartate aminotransferase